Wuhan, China

Junbo Hu

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Wuhan Yicheng Biotech. Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junbo Hu. Retrieved from https://idiyas.com/inventor/junbo-hu-rcqmcqgt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junbo Hu - Innovator in Biotech

Introduction

Junbo Hu is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of biotechnology, particularly in the development of methods for treating diseases associated with abnormal cell proliferation.

Latest Patents

Junbo Hu holds a patent for a polypeptide, along with its nucleotide sequence, which is designed to prevent DNA synthesis and inhibit cell proliferation. The patent describes a polypeptide represented by SEQ ID NO: 1 and outlines a method for treating tumors and other diseases linked to abnormal cell growth. This method involves administering a pharmaceutically effective amount of the polypeptide to patients in need.

Career Highlights

Junbo Hu is associated with Wuhan Yicheng Biotech, Inc., where he continues to work on innovative solutions in biotechnology. His research focuses on developing therapeutic methods that can significantly impact patient care and treatment outcomes.

Collaborations

Some of his notable coworkers include Xianmin Xia and Guihua Wang, who contribute to the collaborative efforts in their research projects.

Conclusion

Junbo Hu's work exemplifies the innovative spirit in biotechnology, with his patent offering promising avenues for cancer treatment and other related diseases. His contributions are vital to advancing medical science and improving patient health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…